Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC35H34ClF3N8O5 |
InChIKeyNCUZLKSDWLCIJF-UHFFFAOYSA-N |
CAS Registry3069346-05-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | United States | 25 Apr 2025 | |
| Neoplasms | Preclinical | India | 25 Apr 2025 |





